Intensity-modulated Arc Therapy Treatment Research Articles

Photon optimizer (PO) vs progressive resolution optimizer (PRO): a conformality- and complexity-based comparison for intensity-modulated arc therapy plans

This study aimed to provide guidance on the advantages and limitations of a new optimizer, “photon optimizer” (PO), when compared with its predecessor, “progressive resolution optimizer” (PRO), for intensity-modulated arc therapy (IMAT) plans.Eleven study plans that included a cohort of prostate, head and neck, and brain treatment sites were optimized using both PRO and PO algorithms. A plan template using the same objectives for the same number of iterations was used for each optimized plan to obtain hypothetical treatment plans that would be comparable with a clinical plan. Analysis was performed using plan conformity-based parameters such as target volume coverage factor, conformation number and homogeneity indices, and plan complexity assessment parameters such as small aperture score, modulation indices, and monitor unit variation with arc angle for prostate, brain and head, and neck IMAT treatment plans.Plan conformality analysis demonstrated that conformation numbers, target volume coverage factors, and homogeneity indices produced by the 2 optimizers were comparable for most anatomic sites. IMAT treatment plans produced using the PRO optimizer were found to be less complex than plans produced using the PO optimizer, in terms of multileaf collimator (MLC) leaf position variability and modulation complexity scores. Similarly, the PRO optimizer was shown to produce treatment plans that used fewer monitor units (and generally fewer monitor unit per degree of arc rotation) than PO optimizer.This study demonstrated that the PO optimizer can produce IMAT treatment plans with a similar degree of dose conformity to the target volume and generally improved organ at risk sparing, compared with the PRO optimizer. Better coverage to organs at risk produced by plans optimized using PO was observed to have higher MLC variability and monitor units. Therefore, careful evaluation of treatment plan conformity and complexity before assessing its deliverability is recommended when implementing the routine use of PO optimizer.

Treatment planning strategy for whole-brain radiotherapy with hippocampal sparing and simultaneous integrated boost for multiple brain metastases using intensity-modulated arc therapy

PurposeTo retrospectively evaluate the accuracy, plan quality and efficiency of intensity-modulated arc therapy (IMAT) for hippocampal sparing whole-brain radiotherapy (HS-WBRT) with simultaneous integrated boost (SIB) in patients with multiple brain metastases (m-BM). Materials and methodsA total of 5 patients with m-BM were retrospectively replanned for HS-WBRT with SIB using IMAT treatment planning. The hippocampus was contoured on diagnostic T1-weighted magnetic resonance imaging (MRI) which had been fused with the planning CT image set. The hippocampal avoidance zone (HAZ) was generated using a 5-mm uniform margin around the paired hippocampi. The m-BM planning target volumes (PTVs) were contoured on T1/T2-weighted MRI registered with the 3D planning computed tomography (CT). The whole-brain planning target volume (WB-PTV) was defined as the whole-brain tissue volume minus HAZ and m-BM PTVs. Highly conformal IMAT plans were generated in the Eclipse treatment planning system for Novalis-TX linear accelerator consisting of high-definition multileaf collimators (HD-MLCs: 2.5-mm leaf width at isocenter) and 6-MV beam. Prescription dose was 30Gy for WB-PTV and 45Gy for each m-BM in 10 fractions. Three full coplanar arcs with orbit avoidance sectors were used. Treatment plans were evaluated using homogeneity (HI) and conformity indices (CI) for target coverage and dose to organs at risk (OAR). Dose delivery efficiency and accuracy of each IMAT plan was assessed via quality assurance (QA) with a MapCHECK device. Actual beam-on time was recorded and a gamma index was used to compare dose agreement between the planned and measured doses. ResultsAll 5 HS-WBRT with SIB plans met WB-PTV D2%, D98%, and V30Gy NRG-CC001 requirements. The plans demonstrated highly conformal and homogenous coverage of the WB-PTV with mean HI and CI values of 0.33 ± 0.04 (range: 0.27 to 0.36), and 0.96 ± 0.01 (range: 0.95 to 0.97), respectively. All 5 hippocampal sparing patients met protocol guidelines with maximum dose and dose to 100% of hippocampus (D100%) less than 16 and 9Gy, respectively. The dose to the optic apparatus was kept below protocol guidelines for all 5 patients. Highly conformal and homogenous radiosurgical dose distributions were achieved for all 5 patients with a total of 33 brain metastases. The m-BM PTVs had a mean HI = 0.09 ± 0.02 (range: 0.07 to 0.19) and a mean CI = 1.02 ± 0.06 (range: 0.93 to 1.2). The total number of monitor units (MU) was, on average, 1677 ± 166. The average beam-on time was 4.1 ± 0.4 minute . The IMAT plans demonstrated accurate dose delivery of 95.2 ± 0.6%, on average, for clinical gamma passing rate with 2%/2-mm criteria and 98.5 ± 0.9%, on average, with 3%/3-mm criteria. ConclusionsAll hippocampal sparing plans were considered clinically acceptable per NRG-CC001 dosimetric compliance criteria. IMAT planning provided highly conformal and homogenous dose distributions for the WB-PTV and m-BM PTVs with lower doses to OAR such as the hippocampus. These results suggest that HS-WBRT with SIB is a clinically feasible, fast, and effective treatment option for patients with a relatively large numbers of m-BM lesions.

Potential for reduced radiation-induced toxicity using intensity-modulated arc therapy for whole-brain radiotherapy with hippocampal sparing.

The purpose of this study was to retrospectively investigate the accuracy, plan quality, and efficiency of using intensity‐modulated arc therapy (IMAT) for whole brain radiotherapy (WBRT) patients with sparing not only the hippocampus (following RTOG 0933 compliance criteria) but also other organs at risk (OARs). A total of 10 patients previously treated with nonconformal opposed laterals whole‐brain radiotherapy (NC‐WBRT) were retrospectively replanned for hippocampal sparing using IMAT treatment planning. The hippocampus was volumetrically contoured on fused diagnostic T1‐weighted MRI with planning CT images and hippocampus avoidance zone (HAZ) was generated using a 5 mm uniform margin around the hippocampus. Both hippocampi were defined as one paired organ. Whole brain tissue minus HAZ was defined as the whole‐brain planning target volume (WB‐PTV). Highly conformal IMAT plans were generated in the Eclipse treatment planning system for Novalis TX linear accelerator consisting of high‐definition multileaf collimators (HD‐MLCs: 2.5 mm leaf width at isocenter) and 6 MV beam for a prescription dose of 30 Gy in 10 fractions following RTOG 0933 dosimetric criteria. Two full coplanar arcs with orbits avoidance sectors were used. In addition to RTOG criteria, doses to other organs at risk (OARs), such as parotid glands, cochlea, external/middle ear canals, skin, scalp, optic pathways, brainstem, and eyes/lens, were also evaluated. Subsequently, dose delivery efficiency and accuracy of each IMAT plan was assessed by delivering quality assurance (QA) plans with a MapCHECK device, recording actual beam‐on time and measuring planed vs. measured dose agreement using a gamma index. On IMAT plans, following RTOG 0933 dosimetric criteria, the maximum dose to WB‐PTV, mean WB‐PTV D2%, and mean WB‐PTV D98% were 34.9±0.3 Gy,33.2±0.4 Gy, and 26.0±0.4 Gy, respectively. Accordingly, WB‐PTV received the prescription dose of 30 Gy and mean V30 was 90.5%±0.5%. The D100%, and mean and maximum doses to hippocampus were 8.4±0.3 Gy,11.2±0.3 Gy, and 15.6±0.4 Gy, on average, respectively. The mean values of homogeneity index (HI) and conformity index (CI) were 0.23×0.02 and 0.96×0.02, respectively. The maximum point dose to WB‐PTV was 35.3 Gy, well below the optic pathway tolerance of 37.5 Gy. In addition, compared to NC‐WBRT, dose reduction of mean and maximum of parotid glands from IMAT were 65% and 50%, respectively. Ear canals mean and maximum doses were reduced by 26% and 12%, and mean and maximum scalp doses were reduced by 9 Gy (32%) and 2 Gy (6%), on average, respectively. The mean dose to skin was 9.7 Gy with IMAT plans compared to 16 Gy with conventional NC‐WBRT, demonstrating that absolute reduction of skin dose by a factor of 2. The mean values of the total number of monitor units (MUs) and actual beam on time were 719×44 and 2.34×0.14 min, respectively. The accuracy of IMAT QA plan delivery was (98.1±0.8) %, on average, with a 3%/3 mm gamma index passing rate criteria. All of these plans were considered clinically acceptable per RTOG 0933 criteria. IMAT planning provided highly conformal and homogenous plan with a fast and effective treatment option for WBRT patients, sparing not only hippocampi but also other OARs, which could potentially result in an additional improvement of the quality life (QoL). In the future, we plan to evaluate the clinical potential of IMAT planning and treatment option with hippocampal and other OARs avoidance in our patient's cohort and asses the QoL of the WBRT patients, as well as simultaneous integrated boost (SIB) for the brain metastases diseases.PACS number: 87

Dosimetric study of two intensity-modulated arc radiotherapy in esophageal cancer

Objective Comparing the dosimetric characteristics of volumetric modulated arc therapy (VMAT) and constant dose rate intensity modulated arc therapy (IMAT) in esophagus cancer to evaluate the performance of the two different arc therapy delivery techniques.Methods 22 cases of esophageal cancer patients were selected for the planning comparison study.All plans were done for IMAT and VMAT treatment plans on Oncentra 4.1 treatment planning system,prescription dose of 2 Gy in total 30 fractions.Planning objectives for PTV were at least 95％ reached the prescription dose and V110 no more than 10％.The maximum dose of spinalcord below 45 Gy and double lung dose V20 ≤ 28％,V30 ≤ 18％ were constrained.Plans were evaluated based on the ability to meet the dose volume histogram.The dose homogeneity index (HI),radiation conformity index (CI),radiation delivery time,monitor units and γ pass rate were also compared.SPSS 19.0 software paired ttest analysis was carried out on the two sets of data.Results The results showed that the IMAT plans in terms of the PTV's CI (t =3.35,P=0.003),D2(t =-2.27,P=0.034) lung's V30(t =-2.46,P=0.023) were better than that of VMAT group.But the VMAT plans spinal's V40 (t =2.37,P =0.027),lung's V5 (t =2.43,P =0.024) were superior to that of IMAT plans.There were no significant differences between IMAT and VMAT plans in the average dose of PTV,CTV,GTV,heart,spinal cord,double lung and the γpass rate.Conclusion IMAT presents a slight improvement in the OAR sparing in high dose with shorter treatment time when compared to VMAT.While in terms of delivered MU and tissue of low dose irradiated area is higher than that of in VMAT.These two treatment methods all can meet the clinical demand,which should be selected according to the actual situation of the patient. Key words: Esophageal neoplasms ; Radiotherapy ; Radiotherapy dosage

New methods in the treatment of localized prostate cancer: use of dynamic arc therapy and kV cone-beam CT positioning

Prostate cancer is a common disease among elderly male patients in developed countries. In addition to prostatectomy, definitive irradiation plays an increasing role in the treatment of localized disease. The authors wanted to share their experience obtained with the use of the Novalis TX linear accelerator for the application of dose-escalation, dynamic, intensity modulated arc therapy with the routine usage of cone-beam computer tomography based or image guided radiotherapy in patients with prostate cancer. Between 2011, December and 2013, February the authors performed 102 treatments. In 10 low risk and 10 high risk prostate cancer patients (median age: 72.5 years) three-dimensional conformal plans with the same target volume coverage were created and tolerance doses of organs at risk (OAR) were compared. Compared to three-dimensional conformal techniques, intensity modulated arc therapy treatments produced a significantly lower dose at organ at risk that led to a more favorable early toxicity rate. The intensity modulated arc therapy with image guided radiotherapy proved to be a safe standard treatment mode in the daily routine in the institute of the authors. Late toxicity and local control rates need to be further examined.

Dosimetric verification for intensity-modulated arc therapy plans by use of 2D diode array, radiochromic film and radiosensitive polymer gel

Several tools are used for the dosimetric verification of intensity-modulated arc therapy (IMAT) treatment delivery. However, limited information is available for composite on-line evaluation of these tools. The purpose of this study was to evaluate the dosimetric verification of IMAT treatment plans using a 2D diode array detector (2D array), radiochromic film (RCF) and radiosensitive polymer gel dosimeter (RPGD). The specific verification plans were created for IMAT for two prostate cancer patients by use of the clinical treatment plans. Accordingly, the IMAT deliveries were performed with the 2D array on a gantry-mounting device, RCF in a cylindrical acrylic phantom, and the RPGD in two cylindrical phantoms. After the irradiation, the planar dose distributions from the 2D array and the RCFs, and the 3D dose distributions from the RPGD measurements were compared with the calculated dose distributions using the gamma analysis method (3% dose difference and 3-mm distance-to-agreement criterion), dose-dependent dose difference diagrams, dose difference histograms, and isodose distributions. The gamma passing rates of 2D array, RCFs and RPGD for one patient were 99.5%, 96.5% and 93.7%, respectively; the corresponding values for the second patient were 97.5%, 92.6% and 92.9%. Mean percentage differences between the RPGD measured and calculated doses in 3D volumes containing PTVs were –0.29 ± 7.1% and 0.97 ± 7.6% for the two patients, respectively. In conclusion, IMAT prostate plans can be delivered with high accuracy, although the 3D measurements indicated less satisfactory agreement with the treatment plans, mainly due to the dosimetric inaccuracy in low-dose regions of the RPGD measurements.

TU‐G‐141‐09: Real Time Estimation of Prostate Tumor Rotation and Translation with a KV Imaging System Based On An Iterative Closest Point Algorithm

Purpose: During cancer radiotherapy a small translation or rotation of the target could be important and change the delivered dose of the treatment. In this work, we implement and test an algorithm to estimate prostate cancer rotation and translation in real‐time using a kV imaging system. Methods: We developed a method based on the iterative closest point (ICP) algorithm and the three dimensional target positions for estimating rotation and shape deformation of prostate in real time. For evaluating our algorithm, 11748 kV images acquired from ten patients during intensity modulated arc therapy treatment (one fraction for each patient were used). The three fiducial markers coordinates were calculated from two dimensional kV images and used as input to the ICP algorithm for investigation of the rotation around three axes. Results: The root mean square error (RMSE) of the rotation matrix was calculated for ICP algorithm and the value was less than 0.16mm. Correlation between all six degrees of freedom shows that the highest correlation belongs to the anterior‐posterior (AP), and superior‐inferior translation with 0.67, and Roll and Yaw rotation with cor=−0.33 has the second highest correlation in our study. The maximum standard deviation (as expected and previously reported) belongs to AP and Roll. Conclusion: a 2D to 6D estimation method has been developed and applied to a 10‐patient dataset. Given the widespread availability of cancer radiotherapy systems with single x‐ray imagers, this method could have a major impact on prostate IGRT, and potentially other cancer sites where three or more implanted markers are routinely placed. Acknowledgement: This work is supported by an NHMRC Australia Fellowship. Jin‐Aun Ng, Jeremy Booth, Thomas Eade, Andrew Kneebone and Walther Fledelius are acknowledged for clinical implementation of the kV intra‐treatment monitoring program.

Intensity-modulated arc therapy using the gate Monte Carlo simulation platform in a grid environment

Introduction The GATE Monte-Carlo (MC) simulation platform ( www.opengatecollaboration.org ) based on the GEANT4 toolkit has come into widespread use for simulating Positron Emission Tomography, Single Photon Emission Computed Tomography, Computing Tomography (CT) imaging devices and radiation therapy. In this work, we explore the simulation of an intensity-modulated arc therapy (IMAT) treatment using GATE 6.2. To reach this objective, we first performed a complete modeling of the Varian's Novalis Tx linear accelerator (15MV photon mode) using the multileaf collimator (MLC). Then, the simulation of the geometry was validated in water before experiencing a head-and-neck cancer treatment. Material and methods The first stage is to model the Novalis Tx head with the GATE MC platform using manufacturer's data. We simulated this linac in 15 MV mode and compared depth doses, in-plane and cross-plane profiles with reference measurements (performed with ionization chambers (Semiflex 31013, PTW and LA48 Linear Array, PTW) and PTW60012 Diode E) in water for several field sizes ranging from 1 × 1 to 10 × 10 cm 2 . Target and flattening filter geometries and initial electron beamare adjusted in order to fit simulation calculations with dosemeasurements. In a second stage, the MLC geometry implementation enabled the simulation of clinical IMAT treatment plans compared with the iPlan treatment planning software (BrainLab) calculations. In order to reduce the computing time of GATE calculations, the simulations are executed on a distributed infrastructure using the GateLab ( http://vip.creatis.insa-lyon.fr/ ) platform. Results Weshowa good agreement between measurements and simulated depth dose profiles in liquid water. GATE and iPlan normalized treatment plans were compared using agammaindex of ±2%/mm.The ongoing work concerning treatment plan comparisons demonstrates limits of the iPlan Pencil Beam algorithm close to heterogeneities. Using the distributed infrastructure, space phase file was produced in 14 h for 500 million primary photons generated reaching a gain of a factor 50 comparing to calculations performed on a single CPU. Conclusions This study demonstrates that GATE offers efficient tools to make possible IMAT applications. In a subsequent work a microdosimetry study should be performed for a complete validation.

Gantry angle determination during arc IMRT: evaluation of a simple EPID-based technique and two commercial inclinometers

The increasing popularity of intensity‐modulated arc therapy (IMAT) treatments requires specifically designed linac quality assurance (QA) programs. Gantry angle is one of the parameters that has a major effect on the outcome of IMAT treatments since dose reconstruction for patient‐specific QA relies on the gantry angle; therefore, it is essential to ensure its accuracy for correct delivery of the prescribed dose. In this study, a simple measurement method and algorithm are presented for QA of gantry angle measurements based on integrated EPID images acquired at distinct gantry angles and cine EPID images during an entire 360° arc. A comprehensive study was carried out to evaluate this method, as well as to evaluate two commercially available inclinometers (NG360 and IBA GAS supplied in conjunction with popular array dosimeters Delta4 and MatriXXEvolution, respectively) by comparing their simultaneous angle measurement results with the linac potentiometer readouts at five gantry speeds. In all tested measurement systems, the average differences with the reference angle data were less than 0.3° in static mode. In arc mode, at all tested gantry speeds the average difference was less than 0.1° for the IBA GAS and the proposed EPID‐based method, and 0.6° for the NG360 after correction for the inherent systematic time delay of the inclinometer. The gantry rotation speed measured by the three independent systems had an average deviation of about 0.01°/s from the nominal gantry speed.PACS numbers: 06.30.Bp; 87.56.Fc; 87.56.‐v

Total-Variation Regularization Based Inverse Planning for Intensity Modulated Arc Therapy

Intensity modulated arc therapy (IMAT) delivers conformal dose distributions through continuous gantry rotation with constant or variable speed while modulating the field aperture shape and weight. The enlarged angular space and machine delivery constraints make inverse planning of IMAT more intractable as compared to its counterpart of fixed gantry IMRT. Currently, IMAT inverse planning is being done using two extreme methods: the first one computes in beamlet domain with a subsequent arc leaf sequencing, and the second proceeds in machine parameter domain with entire emphasis placed on a pre-determined delivery method without exploring potentially better alternative delivery schemes. Towards truly optimizing the IMAT treatment on a patient specific basis, in this work we propose a total-variation based inverse planning framework for IMAT, which takes advantage of the useful features of the above two existing approaches while avoiding their shortcomings. A quadratic optimization algorithm has been implemented to demonstrate the performance and advantage of the proposed approach. Applications of the technique to a prostate case and a head and neck case indicate that the algorithm is capable of generating IMAT plans with patient specific numbers of arcs efficiently. Superior dose distributions and delivery time are achieved with a maximum number of apertures of three for each field. As compared to conventional beamlet-based algorithms, our method regularizes the field modulation complexity during optimization, and permits us to obtain the best possible plan with a pre-set modulation complexity of fluences. As illustrated in both prostate and head-and-neck case studies, the proposed method produces more favorable dose distributions than the segment-based algorithms, by optimally accommodating the clinical need of intensity modulation levels for each individual field. On a more fundamental level, our formulation preserves the convexity of optimization and makes the search of the global optimal solution possible with a deterministic method.

Impact of leaf motion constraints on IMAT plan quality, deliver accuracy, and efficiency

Intensity modulated arc therapy (IMAT) is a radiation therapy delivery technique that combines the efficiency of arc based delivery with the dose painting capabilities of intensity modulated radiation therapy (IMRT). A key challenge in developing robust inverse planning solutions for IMAT is the need to account for the connectivity of the beam shapes as the gantry rotates from one beam angle to the next. To overcome this challenge, inverse planning solutions typically impose a leaf motion constraint that defines the maximum distance a multileaf collimator (MLC) leaf can travel between adjacent control points. The leaf motion constraint ensures the deliverability of the optimized plan, but it also impacts the plan quality, the delivery accuracy, and the delivery efficiency. In this work, the authors have studied leaf motion constraints in detail and have developed recommendations for optimizing the balance between plan quality and delivery efficiency. Two steps were used to generate optimized IMAT treatment plans. The first was the direct machine parameter optimization (DMPO) inverse planning module in the Pinnacle(3) planning system. Then, a home-grown arc sequencer was applied to convert the optimized intensity maps into deliverable IMAT arcs. IMAT leaf motion constraints were imposed using limits of between 1 and 30 mm∕deg. Dose distributions were calculated using the convolution∕superposition algorithm in the Pinnacle(3) planning system. The IMAT plan dose calculation accuracy was examined using a finer sampling calculation and the quality assurance verification. All plans were delivered on an Elekta Synergy with an 80-leaf MLC and were verified using an IBA MatriXX 2D ion chamber array inserted in a MultiCube solid water phantom. The use of a more restrictive leaf motion constraint (less than 1-2 mm∕deg) results in inferior plan quality. A less restrictive leaf motion constraint (greater than 5 mm∕deg) results in improved plan quality but can lead to less accurate dose distribution as evidenced by increasing discrepancies between the planned and the delivered doses. For example, the results from our patient-specific quality assurance measurements demonstrated that the average gamma analysis passing rate decreased from 98% to 80% when the allowable leaf motion increased from 3 to 20 mm∕deg. Larger leaf motion constraints also led to longer treatment delivery times (2 to 4 folds) due to the additional MLC leaf motion. Leaf motion constraints significantly impact IMAT plans in terms of plan quality, delivery accuracy, and delivery efficiency with the impact magnified for more complex cases. Our studies indicate that a leaf motion constraint of 2 to 3 mm∕deg of gantry rotation can provide an optimal balance between plan quality, delivery accuracy, and efficiency.

SU-E-T-556: Interplay Effect Between Dynamic MLC and Moving Target for Lung SBRT with IMAT Technique Delivered by Flattening Filter Free Beam of True Beam Machine

Purpose: To investigate the dosimetric impact of the interplay effect between dynamic MLC and moving target on lungSBRT with intensity‐ modulated arc therapy (IMAT) technique delivered by flattening filter free (FFF) beam of True‐Beam machine. Methods: 6 lungcancer patients with 0.5–1.0 cm tumor motions were investigated in this study. All patients underwent 4DCT scan using audio coaching. For each patient, a 2‐arc IMAT plan was retrospectively generated using Varian RapidArc planning system. Based on the total MU, dose rate and respiratory cycle, the planned MLC control points of IMAT plans were assigned into different respiratory phases. Afterward, 10 new IMAT plans related to different respiratory phases were generated and imported back into Eclipse planning system to calculate the radiationdose on the CTimages of different respiratory phases. In‐house 4D dose calculation program with deformable registration capacity was used to calculate the cumulative doses from all respiratory phases. Following parameters were used to evaluate the dosimetric impacts: dose error (DE), i.e., the difference between the 3D dose of original IMAT plan and the calculated 4‐D dose, and the percentage of volume receiving 100% of the prescribed dose (V100).Results: For all patients, the average maximum DE of PTV and CTV are 32.6% and 4.8%. The DE is larger than 5% for 22% of PTV and 0.3% of CTV volume, and the DE is less than 3% for over 88% of the CTV volume. Compared to the original IMAT plans, the V100 of PTV are lower by 15%. However, the changes on V100 of CTV are less than 1%. Conclusions: For lung IMAT treatment delivered by FFF beam of True‐Beam machine, the interplay effect between dynamic MLC and moving target could change the absolute doses within the target, but its impact on CTV dose coverage is insignificant.

Dosimetric verification of IMAT delivery with a conventional EPID system and a commercial portal dose image prediction tool

The electronic portal imaging device (EPID) is a system for checking the patient setup; as a result of its integration with the linear accelerator and software customized for dosimetry, it is increasingly used for verification of the delivery of fixed-field intensity-modulated radiation therapy (IMRT). In order to extend such an approach to intensity-modulated arc therapy (IMAT), the combined use of an EPID system and a portal dose image prediction (PDIP) tool has been investigated. The dosimetric behavior of an EPID system, mechanically reinforced to maintain its positional stability during the accelerator gantry rotation, has been studied to assess its ability to measure portal dose distributions for IMAT treatment beams. In addition, the PDIP tool of a commercial treatment planning system, commonly used for static IMRT dosimetry, has been validated for simulating the PDIs of IMAT treatment fields. The method has been applied to the delivery verification of 23 treatment fields that were measured in their dual mode of IMRT and IMAT modalities. The EPID system has proved to be appropriate for measuring the PDIs of IMAT fields; additionally the PDIP tool was able to simulate these accurately. The results are quite similar to those obtained for static IMRT treatment verification, although it was necessary to investigate the dependence of the EPID signal and of the accelerator monitor chamber response on variable dose rate. Our initial tests indicate that the EPID system, together with the PDIP tool, is a suitable device for the verification of IMAT plan delivery; however, additional tests are necessary to confirm these results.

Variable dose rate single-arc IMAT delivered with a constant dose rate and variable angular spacing

Single-arc intensity-modulated arc therapy (IMAT) has gained worldwide interest in both research and clinical implementation due to its superior plan quality and delivery efficiency. Single-arc IMAT techniques such as the Varian RapidArc™ deliver conformal dose distributions to the target in one single gantry rotation, resulting in a delivery time in the order of 2 min. The segments in these techniques are evenly distributed within an arc and are allowed to have different monitor unit (MU) weightings. Therefore, a variable dose-rate (VDR) is required for delivery. Because the VDR requirement complicates the control hardware and software of the linear accelerators (linacs) and prevents most existing linacs from delivering IMAT, we propose an alternative planning approach for IMAT using constant dose-rate (CDR) delivery with variable angular spacing. We prove the equivalence by converting VDR-optimized RapidArc plans to CDR plans, where the evenly spaced beams in the VDR plan are redistributed to uneven spacing such that the segments with larger MU weighting occupy a greater angular interval. To minimize perturbation in the optimized dose distribution, the angular deviation of the segments was restricted to ⩽± 5°. This restriction requires the treatment arc to be broken into multiple sectors such that the local MU fluctuation within each sector is reduced, thereby lowering the angular deviation of the segments during redistribution. The converted CDR plans were delivered with a single gantry sweep as in the VDR plans but each sector was delivered with a different value of CDR. For four patient cases, including two head-and-neck, one brain and one prostate, all CDR plans developed with the variable spacing scheme produced similar dose distributions to the original VDR plans. For plans with complex angular MU distributions, the number of sectors increased up to four in the CDR plans in order to maintain the original plan quality. Since each sector was delivered with a different dose rate, extra mode-up time (xMOT) was needed between the transitions of the successive sectors during delivery. On average, the delivery times of the CDR plans were approximately less than 1 min longer than the treatment times of the VDR plans, with an average of about 0.33 min of xMOT per sector transition. The results have shown that VDR may not be necessary for single-arc IMAT. Using variable angular spacing, VDR RapidArc plans can be implemented into the clinics that are not equipped with the new VDR-enabled machines without compromising the plan quality or treatment efficiency. With a prospective optimization approach using variable angular spacing, CDR delivery times can be further minimized while maintaining the high delivery efficiency of single-arc IMAT treatment.

The Intensity Modulated Multiple Arc (IMMA) Technique: Forward & Inverse Planned Procedures to Deliver Hypo- Fractionated IMAT Treatments

Intensity-modulated arc therapy (IMAT) is an arc-based approach to intensity-modulated radiotherapy (IMRT) that can be delivered on a conventional linear accelerator using multiple overlapping arcs. As with other rotational IMRT techniques, IMAT is capable of producing highly conformal dose distributions that are able to compete with the simplest three-dimensional (3D) conformal radiotherapy (CRT) and the most effective static IMRT. Despite its potential, the clinical application of IMAT technique has gone largely unrealized due to the lack of robust and commercially available inverse- planning tools. To overcome this limitation, an in-house forward-planning strategy for planning the IMAT technique, called intensity modulated multiple arcs (IMMA) was developed. This planning approach was implemented for lung and cranial treatments with the aim of generating superior treatment plans compared to the 3D CRT technique. Two treatments plans, on a lung and a cranial tumour respectively, were analyzed as important examples of this new approach. The IMMA plans achieve a similar coverage of the target volumes as well as the 3D CRT technique (coplanar and noncoplanar), but with a better sparing of the critical organs and a delivery efficiency that is superior to that of 3D CRT. This result changes when the comparison is made with the fixed gantry IMRT technique, since the inverse-planned (IP) treatments have a greater flexibility in conforming the dose to the complex targets and in controlling the dose to the critical structures. To improve the IMMA forward-planned procedure, a new IMAT-IP approach has been proposed to obtain treatment plans that approach, in term of tumour dose coverage and dose sparing of the critical organs, the plan quality reached by the IMRT technique.

SU‐FF‐T‐126: Initial Experience with Philips SmartArc On An Elekta Linac

Purpose: The recent introduction of delivery control systems capable of delivering intensity modulated arc therapy (IMAT) has led to renewed interest in arc‐based IMRT delivered on a conventional linac. A key challenge to successful implementation of IMAT is the need for robust inverse planning tools capable of properly accounting for IMAT delivery constraints. In this work, we evaluate a new IMAT planning module, called SmartArc, designed for the Pinnacle3 treatment planning system. Method and Materials: In February 2009, we received an alpha version of the SmartArc planning module for the Pinnacle3 treatment planning system. The SmartArc tools were developed by RaySearch and build on the existing direct machine parameter optimization (DMPO) functionality in Pinnacle3. The SmartArc module was used to create 9 IMAT plans (4 head‐and‐neck, 2 lung, and 3 prostates). Each plan was verified on an Elekta Synergy with the PreciseBeam VMAT delivery control system using the IBA Matrixx 2D ionization chamber array. Each plan was compared with a corresponding fixed‐field IMRT or helical tomotherapy plan in terms of both plan quality and delivery efficiency. Results: A single arc was sufficient to produce highly conformal IMAT treatment plans for the prostate and lung cases. On average, the prostate plans required 536 monitor units and delivered in 1.9 minutes while the lung plans required 750 monitor units and delivered in 2.2 minutes. For the more complex head‐and‐neck cases, the use of two arcs was necessary to meet the treatment goals and an average of 607 monitor units and 5.4 minutes were required. Conclusion: The SmartArc module in Pinnacle3 serves as a robust IMAT planning tool capable of planning both single arc and multiple arc deliveries. 2D gamma analysis showed that all plans verified with greater than 95% of the measured points meeting our 3%/3mm criteria.Research supported by Elekta

DMLC motion tracking of moving targets for intensity modulated arc therapy treatment – a feasibility study

Purpose. Intensity modulated arc therapy offers great advantages with the capability of delivering a fast and highly conformal treatment. However, moving targets represent a major challenge. By monitoring a moving target it is possible to make the beam follow the motion, shaped by a Dynamic MLC (DMLC). The aim of this work was to evaluate the dose delivered to moving targets using the RapidArcTM (Varian Medical Systems, Inc.) technology with and without a DMLC tracking algorithm. Material and methods. A Varian Clinac iX was equipped with a preclinical RapidArcTM and a 3D DMLC tracking application. A motion platform was placed on the couch, with the detectors on top: a PTW seven29 and a Scandidos Delta4. One lung plan and one prostate plan were delivered. Motion was monitored using a Real-time Position Management (RPM) system. Reference measurements were performed for both plans with both detectors at state (0) “static, no tracking”. Comparing measurements were made at state (1) “motion, no tracking” and state (2) “motion, tracking”. Results. Gamma analysis showed a significant improvement from measurements of state (1) to measurements of state (2) compared to the state (0) measurements: Lung plan; from 87 to 97% pass. Prostate plan; from 81 to 88% pass. Sub-beam information gave a much reduced pattern of periodically spatial deviating dose points for state (2) than for state (1). Iso-dose curve comparisons showed a slightly better agreement between state (0) and state (2) than between state (0) and state (1). Conclusions. DMLC tracking together with RapidArcTM make a feasible combination and is capable of improving the dose distribution delivered to a moving target. It seems to be of importance to minimize noise influencing the tracking, to gain the full benefit from the application.

Experimental measurements and Monte Carlo simulations for dosimetric evaluations of intrafraction motion for gated and ungated intensity modulated arc therapy deliveries

Respiratory gated radiation therapy allows for a smaller margin expansion for the planning target volume (PTV) to account for respiratory induced motion and is emerging as a common method to treat lung and liver tumors. We investigated the dosimetric effect of free motion and gated delivery for intensity modulated arc therapy (IMAT) with experimental measurements and Monte Carlo simulations. The impact of PTV margin and duty cycle for gated delivery is studied with Monte Carlo simulations. A motion phantom is used for this study. Two sets of contours were drawn on the mid-inspiration CT scan of this motion phantom. For each set of contours, an IMAT plan to be delivered with constant dose rate was created. The plans were generated on a CT scan of the phantom in the static condition with 3 mm PTV margin and applied to the motion phantom under four conditions: static, full superior–inferior (SI) motion (A = 1 cm, T = 4 s) and gating conditions (25% and 50% duty cycles) with full SI motion. A 6 by 15 cm piece of radiographic film was placed in the sagittal plane of the phantom and then irradiated under all measurement conditions. Film calibration was performed with a step-wedge method to convert optical density to dose. Gated IMAT delivery was first validated in 2D by comparing static film with that from gating and full motion. A previously verified simulation tool for IMRT that takes the log files from the multileaf collimator (MLC) controller and the gating system were adapted to simulate the delivered IMAT treatment for full 3D dosimetric analysis. The IMAT simulations were validated against the 2D film measurements. The resultant IMAT simulations were evaluated with dose criteria, dose-volume histograms and 3D gamma analysis. We validated gated IMAT deliveries when we compared the static film with the one from gating using 25% duty cycle using 2D gamma analysis. Within experimental and setup uncertainties, film measurements agreed with their corresponding simulated plans using 2D gamma analysis. Finally, when planning with margins designed for gating with 25% duty cycle and applying 50% or no gating during treatment, the dose differences in Dmin, D99% and D95% of the clinical target volume can be up to 27 cGy, 20 cGy and 18 cGy, respectively, for a plan with 200 cGy prescription dose. We have experimentally delivered gated IMAT with constant dose rate to a motion phantom and assessed their accuracies with film dosimetry and Monte Carlo simulations. Film dosimetry demonstrated that 25% gating and static plans are within 2%, 2 mm. The Monte Carlo simulation method was employed to generate dose delivered in 3D to a motion phantom, and the dosimetric results were reported. Since our film measurements agreed well with Monte Carlo simulations, we can reliably use this simulation tool to further study the dosimetric effects of target motion and effectiveness of gating for IMAT deliveries.

Dose–volume and biological-model based comparison between helical tomotherapy and (inverse-planned) IMAT for prostate tumours

Background and purpose Helical tomotherapy (HT) and intensity-modulated arc therapy (IMAT) are two arc-based approaches to the delivery of intensity-modulated radiotherapy (IMRT). Through plan comparisons we have investigated the potential of IMAT, both with constant (conventional or IMAT-C) and variable (non-conventional or IMAT-NC, a theoretical exercise) dose-rate, to serve as an alternative to helical tomotherapy. Materials and methods Six patients with prostate tumours treated by HT with a moderately hypo-fractionated protocol, involving a simultaneous integrated boost, were re-planned as IMAT treatments. A method for IMAT inverse-planning using a commercial module for static IMRT combined with a multi-leaf collimator (MLC) arc-sequencing was developed. IMAT plans were compared to HT plans in terms of dose statistics and radiobiological indices. Results Concerning the planning target volume (PTV), the mean doses for all PTVs were similar for HT and IMAT-C plans with minimum dose, target coverage, equivalent uniform dose (EUD) and tumour control probability (TCP) values being generally higher for HT; maximum dose and degree of heterogeneity were instead higher for IMAT-C. In relation to organs at risk, mean doses and normal tissue complication probability (NTCP) values were similar between the two modalities, except for the penile bulb where IMAT was significantly better. Re-normalizing all plans to the same rectal toxicity (NTCP = 5%), the HT modality yielded higher TCP than IMAT-C but there was no significant difference between HT and IMAT-NC. The integral dose with HT was higher than that for IMAT. Conclusions with regards to the plan analysis, the HT is superior to IMAT-C in terms of target coverage and dose homogeneity within the PTV. Introducing dose-rate variation during arc-rotation, not deliverable with current linac technology, the simulations result in comparable plan indices between (IMAT-NC) and HT.

Leaf‐sequencing for intensity‐modulated arc therapy using graph algorithms

Intensity-modulated arc therapy (IMAT) is a rotational IMRT technique. It uses a set of overlapping or nonoverlapping arcs to create a prescribed dose distribution. Despite its numerous advantages, IMAT has not gained widespread clinical applications. This is mainly due to the lack of an effective IMAT leaf-sequencing algorithm that can convert the optimized intensity patterns for all beam directions into IMAT treatment arcs. To address this problem, we have developed an IMAT leaf-sequencing algorithm and software using graph algorithms in computer science. The input to our leaf-sequencing software includes (1) a set of (continuous) intensity patterns optimized by a treatment planning system at a sequence of equally spaced beam angles (typically 10 degrees apart), (2) a maximum leaf motion constraint, and (3) the number of desired arcs, k. The output is a set of treatment arcs that best approximates the set of optimized intensity patterns at all beam angles with guaranteed smooth delivery without violating the maximum leaf motion constraint. The new algorithm consists of the following key steps. First, the optimized intensity patterns are segmented into intensity profiles that are aligned with individual MLC leaf pairs. Then each intensity profile is segmented into k MLC leaf openings using a k-link shortest path algorithm. The leaf openings for all beam angles are subsequently connected together to form 1D IMAT arcs under the maximum leaf motion constraint using a shortest path algorithm. Finally, the 1D IMAT arcs are combined to form IMAT treatment arcs of MLC apertures. The performance of the implemented leaf-sequencing software has been tested for four treatment sites (prostate, breast, head and neck, and lung). In all cases, our leaf-sequencing algorithm produces efficient and highly conformal IMAT plans that rival their counterpart, the tomotherapy plans, and significantly improve the IMRT plans. Algorithm execution times ranging from a few seconds to 2 min are observed on a laptop computer equipped with a 2.0 GHz Pentium M processor.